Table 1.
Clinical characteristic of the participants
| Characteristics | GD patients | Healthy controls |
|---|---|---|
| M/F | 24/56 | 22/43 |
| Age | 36.43±12.82 | 37.60±7.21 |
| M/F | M/F | |
| Alcohol abuse | 4/1 | 3/1 |
| Smoking | 7/6 | 6/5 |
| Skin lesion | 3/6 | 0/0 |
| Ophthalmopathy | 9/20 | 0/0 |
| Thyroid size | ||
| Normal/I | 7/17 | 22/43 |
| II/III | 17/39 | 0/0 |
| FT3 (p mol/L) | 26.82±14.12 | 4.52±1.36 |
| FT4 (p mol/L) | 69.82±29.33 | 16.21±3.58 |
| TSH (m IU/L) | 0.020±0.082 | 1.21±0.73 |
| TgAb (IU/mL) | 673.81±870.48 | Negative |
| TPOAb (IU/mL) | 210.47±211.92 | Negative |
| TRAb (IU/L) | 16.37±14.20 | Negative |
The quantity data are expressed as mean ± standard deviation. M/F: male/female; Normal: thyroid, impalpable and invisible; I: thyroid, palpable and invisible; II/III: thyroid, palpable and visible.